DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0376358 | Malignant neoplasm of prostate | CYP4F8 | 11283 | cytochrome P450 family 4 subfamily F member 8 | P98187 |
C1306459 | Primary malignant neoplasm | MGAT4B | 11282 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B | Q9UQ53 |
C1269683 | Major Depressive Disorder | MGAT4B | 11282 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B | Q9UQ53 |
C0006826 | Malignant Neoplasms | MGAT4B | 11282 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B | Q9UQ53 |
C3150878 | Primary hyperoxaluria type III | HOGA1 | 112817 | 4-hydroxy-2-oxoglutarate aldolase 1 | Q86XE5 |
C0020501 | Primary Hyperoxaluria | HOGA1 | 112817 | 4-hydroxy-2-oxoglutarate aldolase 1 | Q86XE5 |
C0020500 | Hyperoxaluria | HOGA1 | 112817 | 4-hydroxy-2-oxoglutarate aldolase 1 | Q86XE5 |
C0008370 | Cholestasis | HOGA1 | 112817 | 4-hydroxy-2-oxoglutarate aldolase 1 | Q86XE5 |
C0027709 | Nephrocalcinosis | HOGA1 | 112817 | 4-hydroxy-2-oxoglutarate aldolase 1 | Q86XE5 |
C1833683 | NEPHROLITHIASIS, CALCIUM OXALATE | HOGA1 | 112817 | 4-hydroxy-2-oxoglutarate aldolase 1 | Q86XE5 |
C0022661 | Kidney Failure, Chronic | HOGA1 | 112817 | 4-hydroxy-2-oxoglutarate aldolase 1 | Q86XE5 |
C0020505 | Hyperphagia | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0234533 | Generalized seizures | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0010495 | Cutis Laxa | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0023895 | Liver diseases | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C1842836 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0025958 | Microcephaly | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0005695 | Bladder Neoplasm | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C3714756 | Intellectual Disability | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0038273 | Stereotypic Movement Disorder | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0013384 | Dyskinetic syndrome | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0020490 | Hyperopia | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0005684 | Malignant neoplasm of urinary bladder | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C3280127 | MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15 | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0036572 | Seizures | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024